Additionally, exosomal leucine-rich α-2-glycoprotein (LRG1) has been reported as a potential biomarker for lung cancer detection, capable of effectively distinguishing early-stage lung cancer from normal controls using urine samples (Di Bella and Taverna, 2024; Li et al., 2011). Here, LRG1 is linked to lung cancer.